Literature DB >> 26622664

Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures.

Lorenz Kadletz1, Gregor Heiduschka1, Julian Domayer1, Rainer Schmid2, Elisabeth Enzenhofer1, Dietmar Thurnher1.   

Abstract

Two-dimensional (2D) monolayer cell culture models are the most common method used to investigate tumor cells in vitro. In the few last decades, a multicellular spheroid model has gained attention due to its adjacency to tumors in vivo. The aim of the present study was to investigate immunohistochemical differences between these two cell culture systems. The FaDu, CAL27 and SCC25 head and neck squamous cell carcinoma (HNSCC) cell lines were seeded out in monolayer and multicellular spheroids. The FaDu and SCC25 cells were treated with increasing doses of cisplatin and irradiation. CAL27 cells were not used in theproliferation experiments, since the spheroids of CAL27 cells were not able to process the reagent in CCK-8 assays. Furthermore, they were stained to present alterations of the following antigens: Ki-67, vascular endothelial growth factor receptor, epithelial growth factor and survivin. Differences in growth rates and expression patterns were detected in certain HNSCC cell lines. The proliferation rates showed a significant divergence of cells grown in the three-dimensional model compared with cells grown in the 2D model. Overall, multicellular spheroids are a promising method to reproduce the immunohistochemical aspects and characteristics of tumor cells, and may show different response rates to therapeutic options.

Entities:  

Keywords:  cell culture; cisplatin; head and neck squamous cell carcinoma; irradiation; multicellular spheroids

Year:  2015        PMID: 26622664      PMCID: PMC4533713          DOI: 10.3892/ol.2015.3487

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  51 in total

Review 1.  Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR.

Authors:  K H Shain; W S Dalton
Journal:  Mol Cancer Ther       Date:  2001-11       Impact factor: 6.261

2.  Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors.

Authors:  Carla Olsnes; John-Helge Heimdal; Kenneth W Kross; Jan Olofsson; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-19       Impact factor: 2.503

3.  Monocytes secrete interleukin-6 when co-cultured in vitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients.

Authors:  J Heimdal; H J Aarstad; J Olofsson
Journal:  Scand J Immunol       Date:  2000-03       Impact factor: 3.487

4.  Different responses in transformation of MDCK cells in 2D and 3D culture by v-Src as revealed by microarray techniques, RT-PCR and functional assays.

Authors:  Mira Töyli; Linda Rosberg-Kulha; Janne Capra; Jussi Vuoristo; Sinikka Eskelinen
Journal:  Lab Invest       Date:  2010-03-08       Impact factor: 5.662

5.  Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.

Authors:  Ming Yan; Xihu Yang; Lizhen Wang; David Clark; Hui Zuo; Dongxia Ye; Wantao Chen; Ping Zhang
Journal:  Mol Cell Proteomics       Date:  2013-07-31       Impact factor: 5.911

6.  Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.

Authors:  K W Kross; J H Heimdal; C Olsnes; J Olofsson; H J Aarstad
Journal:  Scand J Immunol       Date:  2008-02-12       Impact factor: 3.487

7.  G13 controls angiogenesis through regulation of VEGFR-2 expression.

Authors:  Kishor Kumar Sivaraj; Mikito Takefuji; Inga Schmidt; Ralf H Adams; Stefan Offermanns; Nina Wettschureck
Journal:  Dev Cell       Date:  2013-05-09       Impact factor: 12.270

8.  Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy.

Authors:  Divya Khaitan; Sudhir Chandna; M B Arya; B S Dwarakanath
Journal:  J Transl Med       Date:  2006-03-02       Impact factor: 5.531

9.  Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials.

Authors:  J I Johnson; S Decker; D Zaharevitz; L V Rubinstein; J M Venditti; S Schepartz; S Kalyandrug; M Christian; S Arbuck; M Hollingshead; E A Sausville
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

10.  The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck.

Authors:  Iris Eke; Franziska Leonhardt; Katja Storch; Stephanie Hehlgans; Nils Cordes
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more
  10 in total

1.  Impact of spheroid culture on molecular and functional characteristics of bladder cancer cell lines.

Authors:  Takahiro Yoshida; Nikolai A Sopko; Max Kates; Xiaopu Liu; Gregory Joice; David J Mcconkey; Trinity J Bivalacqua
Journal:  Oncol Lett       Date:  2019-08-29       Impact factor: 2.967

2.  The Limitations of Collagen/CPP Hybrid Peptides as Carriers for Cancer Drugs to FaDu Cells.

Authors:  Kevin Ho; Cristobal Morfin; Katarzyna Slowinska
Journal:  Molecules       Date:  2019-02-14       Impact factor: 4.411

3.  The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer.

Authors:  Styliani Melissaridou; Emilia Wiechec; Mustafa Magan; Mayur Vilas Jain; Man Ki Chung; Lovisa Farnebo; Karin Roberg
Journal:  Cancer Cell Int       Date:  2019-01-14       Impact factor: 5.722

4.  An Effective Primary Head and Neck Squamous Cell Carcinoma In Vitro Model.

Authors:  Felix Oppel; Senyao Shao; Matthias Schürmann; Peter Goon; Andreas E Albers; Holger Sudhoff
Journal:  Cells       Date:  2019-06-07       Impact factor: 6.600

5.  The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas.

Authors:  Fabio Valenti; Andrea Sacconi; Federica Ganci; Giuseppe Grasso; Sabrina Strano; Giovanni Blandino; Silvia Di Agostino
Journal:  Cancers (Basel)       Date:  2019-09-11       Impact factor: 6.639

6.  3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments.

Authors:  Sarah C Brüningk; Ian Rivens; Carol Box; Uwe Oelfke; Gail Ter Haar
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

7.  Stroma-Rich Co-Culture Multicellular Tumor Spheroids as a Tool for Photoactive Drugs Screening.

Authors:  Ilya Yakavets; Samuel Jenard; Aurelie Francois; Yulia Maklygina; Victor Loschenov; Henri-Pierre Lassalle; Gilles Dolivet; Lina Bezdetnaya
Journal:  J Clin Med       Date:  2019-10-15       Impact factor: 4.241

Review 8.  Current Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients.

Authors:  Octav Ginghină; Ariana Hudiță; Cătălin Zaharia; Aristidis Tsatsakis; Yaroslav Mezhuev; Marieta Costache; Bianca Gălățeanu
Journal:  Materials (Basel)       Date:  2021-05-08       Impact factor: 3.623

9.  Reconfigurable Microfluidic Magnetic Valve Arrays: Towards a Radiotherapy-Compatible Spheroid Culture Platform for the Combinatorial Screening of Cancer Therapies.

Authors:  Alexandre R Brunet; Frédérique Labelle; Philip Wong; Thomas Gervais
Journal:  Sensors (Basel)       Date:  2017-10-04       Impact factor: 3.576

10.  Development of an in vitro cell-sheet cancer model for chemotherapeutic screening.

Authors:  Jaewang Lee; Daiha Shin; Jong-Lyel Roh
Journal:  Theranostics       Date:  2018-06-24       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.